Page last updated: 2024-09-05

dronedarone and Recrudescence

dronedarone has been researched along with Recrudescence in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's14 (70.00)24.3611
2020's6 (30.00)2.80

Authors

AuthorsStudies
Akoum, N; Bhatnagar, A; Dagher, L; El Hajjar, AH; Hua, H; Mansour, M; Marrouche, NF; Wazni, O1
Peng, Y; Wang, P; Yan, D; Zhang, Z1
Calkins, H; Corp Dit Genti, V; Hohnloser, SH; Koren, A; Kowey, PR; Torp-Pedersen, CT; Vamos, M; Wieloch, M1
Corp Dit Genti, V; Crijns, HJ; Koren, A; Kowey, PR; Naccarelli, GV; Reiffel, JA; Thind, M; Wieloch, M1
Bhatt, DL; Camm, AJ; Le Heuzey, JY; Lombardi, F; Martinez, JM; Naccarelli, GV; Naditch-Brûlé, L; Tamargo, J1
Blomström-Lundqvist, C; Connolly, S; Corp Dit Genti, V; Hohnloser, SH; Koren, A; Marrouche, N; Wieloch, M1
Blomström-Lundqvist, C; Dagres, N; Lewalter, T; Lip, GY; Pison, L; Proclemer, A1
Braun-Dullaeus, RC; Esperer, HD; Genz, C; Kluba, K; Rauwolf, T; Said, SM; Schmeisser, A1
Clarke, S; Flego, G; Haupt, E; Iannone, P; Magrini, N; Minardi, M; Truglio, P1
Byeon, K; Chun, KJ; Im, SI; Kim, JS; On, YK; Park, KM; Park, SJ1
Barthel, P; Dössel, O; Loewe, A; Lutz, Y; Schmidt, G; Scholz, EP; Seemann, G; Sinnecker, D; Wilhelms, M1
Aliot, EM; Capucci, A; Connolly, S; Crijns, HJ; Guerra, F; Hohnloser, SH; Kowey, PR; Radzik, D; Roy, D1
Adelstein, E; Alam, MB; Jain, SK; Khattak, F; Leef, G; Munir, MB; Patel, D; Qin, D; Rattan, R; Saba, S1
Brent Mitchell, L; Kuriachan, V; Rizkallah, J1
Nguyen, E; White, CM1
Albert, N; Anderson, JL; Buller, CE; Cannom, DS; Creager, MA; Crijns, HJ; Curtis, AB; Ellenbogen, KA; Estes, NA; Ettinger, SM; Ezekowitz, MD; Fuster, V; Guyton, RA; Halperin, JL; Hochman, JS; Jackman, WM; Jacobs, AK; January, CT; Kay, GN; Kushner, FG; Le Heuzey, JY; Lowe, JE; Ohman, EM; Olsson, S; Page, RL; Prystowsky, EN; Rydén, LE; Slotwiner, DJ; Stevenson, WG; Tamargo, JL; Tarkington, LG; Tracy, CM; Wann, LS; Yancy, CW1
Saliba, W; Wazni, OM1
Lunati, M; Pedretti, S1
Caballero, R; Delpón, E; López-Farré, A; Tamargo, J1
Aliot, E; Capucci, A; Connolly, S; Crijns, H; Hohnloser, S; Immordino, L; Kowey, P; Radzik, D; Roy, D1

Reviews

3 review(s) available for dronedarone and Recrudescence

ArticleYear
Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation.
    The Annals of pharmacotherapy, 2017, Volume: 51, Issue:3

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Clinical Trials as Topic; Dronedarone; Drug Therapy, Combination; Humans; Male; Ranolazine; Recurrence; Treatment Outcome

2017
Sinus rhythm restoration and treatment success: insight from recent clinical trials.
    Clinical cardiology, 2011, Volume: 34, Issue:1

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Clinical Trials as Topic; Dronedarone; Electric Countershock; Evidence-Based Medicine; Female; Heart Conduction System; Heart Rate; Humans; Male; Recurrence; Treatment Outcome

2011
Dronedarone.
    Drugs of today (Barcelona, Spain : 1998), 2011, Volume: 47, Issue:2

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Dronedarone; Drug Interactions; Heart Rate; Humans; Recurrence; Treatment Outcome

2011

Trials

5 trial(s) available for dronedarone and Recrudescence

ArticleYear
Effect of DrOnedarone on atrial fibrosis progression and atrial fibrillation recurrence postablation: Design of the EDORA randomized clinical trial.
    Journal of cardiovascular electrophysiology, 2021, Volume: 32, Issue:12

    Topics: Atrial Fibrillation; Catheter Ablation; Contrast Media; Dronedarone; Fibrosis; Gadolinium; Heart Atria; Humans; Prospective Studies; Quality of Life; Recurrence; Treatment Outcome

2021
Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
    Clinical cardiology, 2020, Volume: 43, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Double-Blind Method; Dronedarone; Female; Heart Rate; Hospitalization; Humans; Male; Middle Aged; Recurrence; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2020
Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies.
    Journal of cardiovascular pharmacology and therapeutics, 2020, Volume: 25, Issue:5

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Drug Substitution; Female; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome

2020
Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study.
    Clinical cardiology, 2020, Volume: 43, Issue:12

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Electrocardiography; Female; Heart Rate; Humans; Male; Recurrence; Treatment Outcome

2020
Efficacy of dronedarone versus propafenone in the maintenance of sinus rhythm in patients with atrial fibrillation after electrical cardioversion.
    Clinical therapeutics, 2014, Sep-01, Volume: 36, Issue:9

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Dronedarone; Electric Countershock; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Propafenone; Recurrence; Time Factors

2014

Other Studies

12 other study(ies) available for dronedarone and Recrudescence

ArticleYear
Efficacy and Safety of Sustained-Release Metoprolol With Dronedarone After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation: A Propensity Matched Analysis.
    The American journal of cardiology, 2022, 12-15, Volume: 185

    Topics: Atrial Fibrillation; Catheter Ablation; Delayed-Action Preparations; Dronedarone; Humans; Metoprolol; Quality of Life; Recurrence; Retrospective Studies; Treatment Outcome

2022
Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
    Journal of cardiovascular electrophysiology, 2020, Volume: 31, Issue:5

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials, Phase III as Topic; Dronedarone; Electric Countershock; Europe; Female; Heart Rate; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Retreatment; Risk Assessment; Risk Factors; Sulfonamides; Time Factors; Treatment Outcome; United States

2020
Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2013, Volume: 15, Issue:4

    Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Dronedarone; Electrocardiography; Europe; Guideline Adherence; Health Care Surveys; Humans; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Predictive Value of Tests; Recurrence; Treatment Outcome

2013
Which patient is most likely to benefit from dronedarone? Analysis from the Magdeburg Dronedarone Registry (MADRE study).
    Journal of clinical pharmacology, 2013, Volume: 53, Issue:8

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Female; Heart Atria; Humans; Male; Middle Aged; Organ Size; Recurrence; Registries

2013
Dronedarone for atrial fibrillation: the limited reliability of clinical practice guidelines.
    JAMA internal medicine, 2014, Volume: 174, Issue:4

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Dronedarone; Evidence-Based Medicine; Heart Rate; Humans; Practice Guidelines as Topic; Recurrence; Reproducibility of Results; United States

2014
In-silico assessment of the dynamic effects of amiodarone and dronedarone on human atrial patho-electrophysiology.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16 Suppl 4

    Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Computer Simulation; Dose-Response Relationship, Drug; Dronedarone; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Heart Atria; Heart Rate; Humans; Models, Cardiovascular; Mutation; Numerical Analysis, Computer-Assisted; Recurrence; Time Factors; Treatment Outcome

2014
Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
    Clinical cardiology, 2014, Volume: 37, Issue:12

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Dronedarone; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Sotalol

2014
Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
    Journal of cardiology, 2016, Volume: 67, Issue:5

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Dronedarone; Female; Humans; Male; Patient Admission; Pennsylvania; Phenethylamines; Recurrence; Retrospective Studies; Sotalol; Stroke; Sulfonamides

2016
The use of dronedarone for recurrent ventricular tachycardia: a case report and review of the literature.
    BMC research notes, 2016, Jul-27, Volume: 9

    Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Dronedarone; Fatal Outcome; Humans; Male; Multiple Organ Failure; Nausea; Off-Label Use; Recurrence; Tachycardia, Ventricular; Treatment Failure

2016
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    Heart rhythm, 2011, Volume: 8, Issue:1

    Topics: Algorithms; Amiodarone; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Combined Modality Therapy; Dronedarone; Evidence-Based Medicine; Humans; Platelet Aggregation Inhibitors; Recurrence; Treatment Outcome

2011
[Treatment of atrial fibrillation: when to use drugs or to perform ablation].
    Giornale italiano di cardiologia (2006), 2010, Volume: 11, Issue:10 Suppl 1

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Clinical Trials as Topic; Dronedarone; Follow-Up Studies; Humans; Male; Middle Aged; Postoperative Complications; Recurrence; Time Factors; Treatment Outcome

2010
Effects of dronedarone started rapidly after amiodarone discontinuation.
    Clinical cardiology, 2013, Volume: 36, Issue:2

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Dronedarone; Drug Substitution; Female; Half-Life; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Patient Selection; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome

2013